- call +1-201-465-4211
- email sales@mrinsights.biz
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
Scope of the Report:
This report focuses on the Infertility Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The five major types of ovulation drug therapy are Clomid (Serophene, clomiphene citrate), Femara or letrozole and other aromatase inhibitors, injectable gonadotropins and injectable FSH hormone products, the GnRH pump and Bromocriptine.
The worldwide market for Infertility Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Bayer
Ferring
Merck
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Clomid
Femara or letrozole
Injectable gonadotropins and injectable FSH hormone products
The GnRH pump
Bromocriptine
Market Segment by Applications, can be divided into
Male
Female
There are 15 Chapters to deeply display the global Infertility Drugs market.
Chapter 1, to describe Infertility Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Infertility Drugs, with sales, revenue, and price of Infertility Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Infertility Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Infertility Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Infertility Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Infertility Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Clomid
1.2.2 Femara or letrozole
1.2.3 Injectable gonadotropins and injectable FSH hormone products
1.2.4 The GnRH pump
1.2.5 Bromocriptine
1.3 Market Analysis by Applications
1.3.1 Male
1.3.2 Female
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Infertility Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Ferring
2.2.1 Business Overview
2.2.2 Infertility Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ferring Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Infertility Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Infertility Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Infertility Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Infertility Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Infertility Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Infertility Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Infertility Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Infertility Drugs Market Analysis by Regions
4.1 Global Infertility Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Infertility Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Infertility Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Infertility Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Infertility Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Infertility Drugs Sales and Growth Rate (2013-2018)
4.5 South America Infertility Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Infertility Drugs Sales and Growth Rate (2013-2018)
5 North America Infertility Drugs by Countries
5.1 North America Infertility Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Infertility Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Infertility Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Infertility Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Infertility Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Infertility Drugs Sales and Growth Rate (2013-2018)
6 Europe Infertility Drugs by Countries
6.1 Europe Infertility Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Infertility Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Infertility Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Infertility Drugs Sales and Growth Rate (2013-2018)
6.3 UK Infertility Drugs Sales and Growth Rate (2013-2018)
6.4 France Infertility Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Infertility Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Infertility Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Infertility Drugs by Countries
7.1 Asia-Pacific Infertility Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Infertility Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Infertility Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Infertility Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Infertility Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Infertility Drugs Sales and Growth Rate (2013-2018)
7.5 India Infertility Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Infertility Drugs Sales and Growth Rate (2013-2018)
8 South America Infertility Drugs by Countries
8.1 South America Infertility Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Infertility Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Infertility Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Infertility Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Infertility Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Infertility Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Infertility Drugs by Countries
9.1 Middle East and Africa Infertility Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Infertility Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Infertility Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Infertility Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Infertility Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Infertility Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Infertility Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Infertility Drugs Sales and Growth Rate (2013-2018)
10 Global Infertility Drugs Market Segment by Type
10.1 Global Infertility Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Infertility Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Infertility Drugs Revenue and Market Share by Type (2013-2018)
10.2 Clomid Sales Growth and Price
10.2.1 Global Clomid Sales Growth (2013-2018)
10.2.2 Global Clomid Price (2013-2018)
10.3 Femara or letrozole Sales Growth and Price
10.3.1 Global Femara or letrozole Sales Growth (2013-2018)
10.3.2 Global Femara or letrozole Price (2013-2018)
10.4 Injectable gonadotropins and injectable FSH hormone products Sales Growth and Price
10.4.1 Global Injectable gonadotropins and injectable FSH hormone products Sales Growth (2013-2018)
10.4.2 Global Injectable gonadotropins and injectable FSH hormone products Price (2013-2018)
10.5 The GnRH pump Sales Growth and Price
10.5.1 Global The GnRH pump Sales Growth (2013-2018)
10.5.2 Global The GnRH pump Price (2013-2018)
10.6 Bromocriptine Sales Growth and Price
10.6.1 Global Bromocriptine Sales Growth (2013-2018)
10.6.2 Global Bromocriptine Price (2013-2018)
11 Global Infertility Drugs Market Segment by Application
11.1 Global Infertility Drugs Sales Market Share by Application (2013-2018)
11.2 Male Sales Growth (2013-2018)
11.3 Female Sales Growth (2013-2018)
12 Infertility Drugs Market Forecast (2018-2023)
12.1 Global Infertility Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Infertility Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Infertility Drugs Market Forecast (2018-2023)
12.2.2 Europe Infertility Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Infertility Drugs Market Forecast (2018-2023)
12.2.4 South America Infertility Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Infertility Drugs Market Forecast (2018-2023)
12.3 Infertility Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Infertility Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Infertility Drugs Market Share Forecast by Type (2018-2023)
12.4 Infertility Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Infertility Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Infertility Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Infertility Drugs Picture
Table Product Specifications of Infertility Drugs
Figure Global Sales Market Share of Infertility Drugs by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
